Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
Similar Companies1000
AryoGen Pharmed
AryoGen Pharmed is a biopharmaceutical manufacturer that aims to improve the quality of life of patients with life-threatening diseases.
Sector
Subsector
Location
Cho Pharma
CHO Pharma is an international leader in sugar molecule related technology, improving the quality of medical care for patients.
Sector
Subsector
Keywords
Location
Paratek Pharmaceuticals
Paratek Pharmaceuticals develops and sells innovative therapies using tetracycline chemistry.
Sector
Subsector
Location
total rounds
total raised
Amylin Pharmaceuticals
Amylin Pharmaceuticals is a biopharmaceutical company that develops and commercializes drugs, with a focus on diabetes and obesity.
Sector
Subsector
Keywords
Location
total rounds
count Of Investments
count Of Exists
Financials
Funding Rounds8
Number of Funding Rounds
Money Raised
Their latest funding was raised on 07.06.2024. Their latest round Post-IPO Debt
Co-Investors
Investors6
Number of lead investors
Number of investors
Aztiq Pharma
Icelandic biopharmaceutical company, Aztiq Pharma.
Sector
Subsector
Location
count Of Investments
Baxter Ventures
Baxter Ventures invests in innovative healthcare companies to improve patient care and maximize value for investors and entrepreneurs.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Shinhan Capital
Shinhan Capital is a credit-specialized company that provides corporate finance services to its clients.
Sector
Subsector
Keywords
Location
count Of Investments
People
Founders1
Róbert Wessman
Róbert Wessman became the Executive Chairman of Alvogen in July 2009 and is now Chairman & CEO of the group. Since founding the business five years ago, Róbert has grown Alvogen from a small US business into an international pharmaceuticals company with commercial operations in 35 countries and with 2,300 employees. Róbert Wessmann is the founder of Alvotech. Under Wessman’s leadership, Alvogen has set a clear goal to become a top ten global generics player, and is making strong progress towards that ambition. Wessman’s vision to create an organisation which is able to respond to the needs of its customers has led to the development of a balanced yet specialised portfolio consisting of 500 marketed products, as well as a deep pipeline of high-value products in development.
current job
Róbert Wessman
Employee Profiles20
Philip Caramanica
Chief IP Counsel and Deputy General Counsel
Activity
Recent News34
The graph reveals the ratio (%) of positive news articles in a chosen time range